BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33691613)

  • 1. E2F1 copy number variations in germline and breast cancer: a retrospective study of 222 Italian women.
    Rocca MS; Benna C; Goldin E; Di Nisio A; De Toni L; Cosci I; Marchet A; Nitti D; Foresta C
    Mol Med; 2021 Mar; 27(1):26. PubMed ID: 33691613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F1 germline copy number variations and melanoma susceptibility.
    Rocca MS; Benna C; Mocellin S; Rossi CR; Msaki A; Di Nisio A; Opocher G; Foresta C
    J Transl Med; 2019 May; 17(1):181. PubMed ID: 31142321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F1 copy number variations contribute to spermatogenic impairment and cryptorchidism by increasing susceptibility to heat stress.
    Rocca MS; Di Nisio A; Sabovic I; Ghezzi M; Foresta C; Ferlin A
    Andrology; 2019 Mar; 7(2):251-256. PubMed ID: 30659775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number variations of
    Rocca MS; Di Nisio A; Marchiori A; Ghezzi M; Opocher G; Foresta C; Ferlin A
    Endocr Relat Cancer; 2017 Mar; 24(3):119-125. PubMed ID: 28104681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry.
    Walker LC; Pearson JF; Wiggins GA; Giles GG; Hopper JL; Southey MC
    Breast Cancer Res; 2017 Mar; 19(1):30. PubMed ID: 28302160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia.
    Jorgez CJ; Wilken N; Addai JB; Newberg J; Vangapandu HV; Pastuszak AW; Mukherjee S; Rosenfeld JA; Lipshultz LI; Lamb DJ
    Fertil Steril; 2015 Jan; 103(1):44-52.e1. PubMed ID: 25439843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline copy number variations are associated with breast cancer risk and prognosis.
    Kumaran M; Cass CE; Graham K; Mackey JR; Hubaux R; Lam W; Yasui Y; Damaraju S
    Sci Rep; 2017 Nov; 7(1):14621. PubMed ID: 29116104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline copy number variants are not associated with globally acquired copy number changes in familial breast tumours.
    Walker LC; Krause L; ; Spurdle AB; Waddell N
    Breast Cancer Res Treat; 2012 Aug; 134(3):1005-11. PubMed ID: 22434526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline copy number variations associated with breast cancer susceptibility in a Japanese population.
    Suehiro Y; Okada T; Shikamoto N; Zhan Y; Sakai K; Okayama N; Nishioka M; Furuya T; Oga A; Kawauchi S; Maeda N; Tamesa M; Nagashima Y; Yamamoto S; Oka M; Hinoda Y; Sasaki K
    Tumour Biol; 2013 Apr; 34(2):947-52. PubMed ID: 23275252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline DNA copy number variation in familial and early-onset breast cancer.
    Krepischi AC; Achatz MI; Santos EM; Costa SS; Lisboa BC; Brentani H; Santos TM; Gonçalves A; Nóbrega AF; Pearson PL; Vianna-Morgante AM; Carraro DM; Brentani RR; Rosenberg C
    Breast Cancer Res; 2012 Feb; 14(1):R24. PubMed ID: 22314128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer associated germline structural variants harboring small noncoding RNAs impact post-transcriptional gene regulation.
    Kumaran M; Krishnan P; Cass CE; Hubaux R; Lam W; Yasui Y; Damaraju S
    Sci Rep; 2018 May; 8(1):7529. PubMed ID: 29760470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation.
    Montenegro MF; Sáez-Ayala M; Piñero-Madrona A; Cabezas-Herrera J; Rodríguez-López JN
    PLoS One; 2012; 7(12):e52231. PubMed ID: 23251702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression network.
    Pylkäs K; Vuorela M; Otsukka M; Kallioniemi A; Jukkola-Vuorinen A; Winqvist R
    PLoS Genet; 2012; 8(6):e1002734. PubMed ID: 22737080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
    Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
    Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Genome-Wide Association Study to Identify Potential Germline Copy Number Variants for Sporadic Breast Cancer Susceptibility.
    Sapkota Y; Narasimhan A; Kumaran M; Sehrawat BS; Damaraju S
    Cytogenet Genome Res; 2016; 149(3):156-164. PubMed ID: 27668787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of a tumour suppressive function of E2F1 gene in human breast cancer.
    Worku D; Jouhra F; Jiang GW; Patani N; Newbold RF; Mokbel K
    Anticancer Res; 2008; 28(4B):2135-9. PubMed ID: 18751386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation.
    Li D; Bi FF; Cao JM; Cao C; Liu B; Yang Q
    Mol Cancer; 2014 Feb; 13():26. PubMed ID: 24502362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large germline copy number variations as predisposing factor in childhood neoplasms.
    Krepischi AC; Capelli LP; Silva AG; de Araújo ÉS; Pearson PL; Heck B; da Costa CM; de Camargo B; Rosenberg C
    Future Oncol; 2014; 10(9):1627-33. PubMed ID: 25145432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome.
    Vuaroqueaux V; Urban P; Labuhn M; Delorenzi M; Wirapati P; Benz CC; Flury R; Dieterich H; Spyratos F; Eppenberger U; Eppenberger-Castori S
    Breast Cancer Res; 2007; 9(3):R33. PubMed ID: 17535433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.